Str (Images 1)
Chemical structure of Pomalidomide, showing the molecular arrangement including aromatic rings, amine group, and carbonyl functional groups.*
Pomalidomide Capsule
Product Images NDC 0480-4018
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 0480-4018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Images 2)
A Kaplan-Meier plot illustrating progression free survival over months for two treatment groups: HD-DEX and POM+LD-DEX. The y-axis represents the proportion of subjects, and the x-axis shows time in months. The chart includes statistical details such as the hazard ratio, confidence interval, median survival times, and the number of subjects at risk at various time points.*
Figure 2 (Images 3)
A Kaplan-Meier survival curve comparing overall survival in months between two treatment groups: HD-DEX and POM+LD-DEX. The graph shows the proportion of subjects surviving over time with a table below indicating the number of subjects at risk at various time points for each group. Statistical results including logrank p-value, hazard ratio with confidence intervals, median survival times, and events count are shown in the graph.*
1mg21s (Images 4)
Pomalidomide Capsules 1 mg label for oral capsules by Teva Pharmaceuticals, Inc. The label includes a warning about potential human birth defects, instructions to dispense the accompanying medication guide, storage temperature guidelines, and a note on dispensing in a tight, light-resistant container. The package contains 21 capsules with an NDC of 0480-4018-21.*
2mg21s (Images 5)
Label for Pomalidomide Capsules 2 mg oral capsules by Teva Pharmaceuticals, Inc. The label includes the NDC 0480-4022-21 and indicates a package size of 21 capsules. It features a boxed warning for potential human birth defects, storage instructions, and dispensing guidance. The label also provides a web address for medication guides and the manufacturer’s location in Parsippany, NJ.*
3mg21s (Images 6)
Pomalidomide 3 mg capsules packaging label by Teva Pharmaceuticals, Inc. The label includes the product name and strength, a warning about potential birth defects, pharmacist dispensing instructions to provide the Medication Guide, and storage conditions. It also shows the package size of 21 capsules and the manufacturer location in Parsippany, NJ.*
4mg21s (Images 7)
Pomalidomide 4 mg oral capsules packaging label by Teva Pharmaceuticals, Inc. The label includes the product name, strength, capsule count (21 capsules), and a warning about the potential for human birth defects. Directions indicate prescription-only use and advise pharmacists to provide a Medication Guide with each dispensation. Storage instructions and manufacturer information are also present.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
